Peer-reviewedLicence not statedScience Translational Medicine
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant
39 affiliations
- 1Leukemia Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 2Department of Pediatrics, Harvard Medical School and Divisions of Infectious Diseases and Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA
- 3Adaptive Biotechnologies, Seattle, WA, USA
- 4Department of Medicine, Medical College of Wisconsin and Center for International Blood and Marrow Transplant Research (CIBMTR), Milwaukee, WI, USA
- 5Division of Hematology/Oncology, Boston Children’s Hospital, Boston, MA, USA
- 6Harvard Medical School, Boston, MA, USA
- 7CIBMTR and Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA
- 8CIBMTR and Division of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, USA
- 9Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- 10Broad Institute of the Massachusetts Institute of Technology and Harvard, Cambridge, MA, USA
- 11Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA
- 12Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA
- 13Emmes, Rockville, MD, USA
- 14Division of Hematology/Oncology, Mayo Clinic, Phoenix, AZ, USA
- 15Department of Pediatrics, University of Michigan, Ann Arbor, MI, USA
- 16Division of Hematology–Oncology and Palliative Care, Virginia Commonwealth University, Richmond, VA, USA
- 17Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN, USA
- 18Department of Hematology and Hematopoietic Cell Transplantation, City of Hope, Duarte, CA, USA
- 19Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University and the Department of Oncology, Johns Hopkins University School of Medicine, Baltimore, MD, USA
- 20Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA
- 21Division of Hematology-Oncology and Blood and Marrow Transplant and Cellular Therapy Programs, Mayo Clinic, Jacksonville, FL, USA
- 22CIBMTR, Milwaukee, WI, USA
- 23Division of Hematologic Malignancies and Cellular Therapy, Kansas University Medical Center, Kansas City, KS, USA
- 24Ohio State University Comprehensive Cancer Center, Columbus, OH, USA
- 25Department of Hematology and Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
- 26Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer and Research Institute, Tampa, FL, USA
- 27Department of Stem Cell Transplantation and Cellular Therapy, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
- 28Division of Hematology and Oncology, Medical College of Wisconsin, Milwaukee, WI, USA
- 29Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
- 30Department of Medicine, Weill Cornell Medical College, New York, NY, USA
- 31Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University School of Medicine, Stanford, CA, USA
- 32Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
- 33Immune Deficiency Cellular Therapy Program, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA
- 34Division of Hematology and Oncology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA
- 35Center for International Blood and Marrow Transplant Research, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA
- 36Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center and Department of Immunology, University of Washington, Seattle, WA, USA
- 37Blood and Marrow Transplantation Section, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
- 38Division of Hematology, Departments of Medicine and Genetics, Stanford University, Palo Alto, CA, USA
- 39Department of Pediatrics, Harvard Medical School, Division of Hematology/Oncology, Boston Children’s Hospital, and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, USA
Related
- Kinetics of early immune reconstitution and its exploratory association with post-transplant outcomes in patients undergoing haploidentical HCT with post-transplant cyclophosphamide-based GvHD prophylaxis
- Surveillance of CMV Terminase Gene Mutations in Allogeneic Hematopoietic Stem Cell Transplant Recipients Receiving Letermovir Prophylaxis
- Mucormycosis in adult hematopoietic stem cell transplant recipients during the antifungal prophylaxis era: a single-center retrospective case series
- Hematopoietic Cell Transplantation in Children with Sickle Cell Disease: A Single-Center Experience and Exploration of an Age Threshold for Post-Transplant Complications
- Incidence and Outcomes of Human Adenovirus Infection and Disease in a Multicenter Cohort of Pediatric Allogeneic Hematopoietic Cell Transplant Recipients
BibTeX
@article{dewolf2026graftversushost,
title = {{Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant}},
author = {Susan DeWolf and Steven J. Siegel and Joseph Schmalz and Wael Saber and Alexandre Albanese and Jiayi Dong and Michael J. Martens and Brent R. Logan and Lorenzo Iovino and Kayleigh Ingersoll Omdahl and Nicholas Winn and Edward Chen and James J. Kaminski and Donna S Neuberg and Kyle M. Hebert and Paula Keskula and Jillian Zavistaski and Lea Steinberg and Isabella Schichter and Zoe Katsamakis and Lorenzo S Cagnin and Vanessa A Hernandez and Makya Warren and Kristy Applegate and Merav Bar and Saurabh Chhabra and Sung Won Choi and William Clark and Suman R. Das and Robert R. Jenq and Richard John Jones and John E. Levine and Hemant S. Murthy and Armin Rashidi and Marcie Riches and Karamjeet Sandhu and Anthony Derek Sung and Karilyn T. M. Larkin and Monzr M. Al Malki and Mahasweta Gooptu and Hany Elmariah and Amin Majid Alousi and Lyndsey Runaas and Brian C. Shaffer and Andrew R. Rezvani and Najla El Jurdi and Alison Wakoff Loren and Danielle Scheffey and Catherine Miller Sanders and Mehdi Hamadani and Jarrod A. Dudakov and Stephanie A. Bien and Harlan S. Robins and Mary Horowitz and Javier Bolaños‐Meade and Shernan G. Holtan and Ami Siddharth Bhatt and Miguel‐Angel Perales and Leslie S. Kean},
journal = {Science Translational Medicine},
year = {2026},
month = oct,
doi = {10.1126/scitranslmed.aef7406},
url = {https://doi.org/10.1101/2025.02.25.25322901},
}
RIS
TY - JOUR
TI - Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant
AU - Susan DeWolf
AU - Steven J. Siegel
AU - Joseph Schmalz
AU - Wael Saber
AU - Alexandre Albanese
AU - Jiayi Dong
AU - Michael J. Martens
AU - Brent R. Logan
AU - Lorenzo Iovino
AU - Kayleigh Ingersoll Omdahl
AU - Nicholas Winn
AU - Edward Chen
AU - James J. Kaminski
AU - Donna S Neuberg
AU - Kyle M. Hebert
AU - Paula Keskula
AU - Jillian Zavistaski
AU - Lea Steinberg
AU - Isabella Schichter
AU - Zoe Katsamakis
AU - Lorenzo S Cagnin
AU - Vanessa A Hernandez
AU - Makya Warren
AU - Kristy Applegate
AU - Merav Bar
AU - Saurabh Chhabra
AU - Sung Won Choi
AU - William Clark
AU - Suman R. Das
AU - Robert R. Jenq
AU - Richard John Jones
AU - John E. Levine
AU - Hemant S. Murthy
AU - Armin Rashidi
AU - Marcie Riches
AU - Karamjeet Sandhu
AU - Anthony Derek Sung
AU - Karilyn T. M. Larkin
AU - Monzr M. Al Malki
AU - Mahasweta Gooptu
AU - Hany Elmariah
AU - Amin Majid Alousi
AU - Lyndsey Runaas
AU - Brian C. Shaffer
AU - Andrew R. Rezvani
AU - Najla El Jurdi
AU - Alison Wakoff Loren
AU - Danielle Scheffey
AU - Catherine Miller Sanders
AU - Mehdi Hamadani
AU - Jarrod A. Dudakov
AU - Stephanie A. Bien
AU - Harlan S. Robins
AU - Mary Horowitz
AU - Javier Bolaños‐Meade
AU - Shernan G. Holtan
AU - Ami Siddharth Bhatt
AU - Miguel‐Angel Perales
AU - Leslie S. Kean
PY - 2026
DA - 2026/10/21
JO - Science Translational Medicine
DO - 10.1126/scitranslmed.aef7406
UR - https://doi.org/10.1101/2025.02.25.25322901
SN - 1946-6234
SN - 1946-6242
ER -